Dr. Yuki Yoshimatsu | Nanoscale | Women Researcher Award

Dr. Yuki Yoshimatsu | Nanoscale | Women Researcher Award

Dr. Yuki Yoshimatsu at Tochigi Cancer Center, Japan

Dr. Yuki Yoshimatsu is a leading cancer biologist and Project Leader at the Tochigi Cancer Center Research Institute, Japan. She holds a Ph.D. in Medical Science from the University of Tokyo and has extensive experience in rare cancer research, particularly sarcomas. Her career includes senior roles at the National Cancer Center Research Institute in Tokyo and postdoctoral training at the University of Washington, USA. Her research focuses on patient-derived cancer models, drug sensitivity screening, kinomic profiling, and biomarker discovery for precision oncology. She has established over 100 rare cancer models and contributed to national clinical guidelines. Dr. Yoshimatsu is also committed to mentoring young female scientists and advancing translational oncology through international collaboration.

Professional Profile:

ORCID

Summary of Suitability for Women Researcher Award: Dr. Yuki Yoshimatsu

Dr. Yuki Yoshimatsu exemplifies excellence in biomedical research and leadership in translational oncology, making her a highly deserving candidate for the Women Researcher Award. With a Ph.D. in Medical Science from the University of Tokyo and extensive research experience at prestigious institutions including the National Cancer Center Japan and the University of Washington, Dr. Yoshimatsu has established herself as a leading figure in rare cancer biology.

🎓 Education

Ph.D. in Medical Science
🏛️ University of Tokyo, Graduate School of Medicine
🧬 Department of Pathology
📍 Tokyo, Japan

💼 Professional Experience

Project Leader
🏥 Tochigi Cancer Center Research Institute
📍 Tochigi, Japan | ⏳ 2022 – Present
🔬 Leading translational research in rare cancers and biomarker development

Senior Researcher
🧪 National Cancer Center Research Institute
📍 Tokyo, Japan | ⏳ 2016 – 2022
🧫 Established multiple patient-derived sarcoma models and conducted drug sensitivity profiling

Postdoctoral Fellow
🧬 University of Washington, Dept. of Otolaryngology
📍 Seattle, WA, USA | ⏳ 2012 – 2016
🌎 International research in viral oncogenesis and multi-step carcinogenesis

🧪 Research Interests

🧫 Rare cancers (esp. sarcomas)

🧬 Patient-derived cancer models (cell lines, organoids, xenografts)

💊 Drug sensitivity screening & kinomic profiling

🧠 Biomarker discovery for precision oncology

🦠 Viral oncogenesis & multi-step carcinogenesis

🏆 Honors & Awards

🥇 Best Presentation Award
“Establishment and characterization of a novel leiomyosarcoma cell line”
📅 Aug 2023 | 🧬 Japanese Society of Human Cell Science

🏅 Poster Award
“Construction of patient-derived sarcoma models”
📅 Nov 2021 | 🔬 Japan Society for Patient-Derived Cancer Models

🌍 International Research Grant
“Mechanisms of multi-step carcinogenesis in cervical cancer”
📅 Mar 2010 | 🧪 Kanzawa Medical Research Promotion Foundation

Publication Top Notes

Pharmacokinomic Profiling Using Patient-Derived Cell Lines Predicts Sensitivity to Imatinib in Dermatofibrosarcoma Protuberans

Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1

 

Prof. Pinglin Li | self assembly Awards | Best Researcher Award

Prof. Pinglin Li | self assembly Awards | Best Researcher Award

Prof. Pinglin Li, Ocean University of China, China

Dr. Li Pinglin is a distinguished professor at the School of Medicine and Pharmacy, Ocean University of China, specializing in organic chemistry and marine bioactive compounds. With over a decade of experience in marine natural product chemistry, his work focuses on the isolation and bioassay of secondary metabolites from invertebrates in the South China Sea. Dr. Li’s research involves structural determination using quantum calculation methods and semi-synthesis of marine-derived bioactive natural products. His work has contributed significantly to the discovery of novel compounds with promising pharmacological properties. Dr. Li has received the prestigious Sanofi Biopharmaceuticals Award for Youth from the Chinese Pharmaceutical Association in 2013. He has also held several key research grants, including from the National Natural Science Foundation of China, leading projects focused on marine natural products and their applications in medicine.

Professional Profile:

Orcid

Suitability for the Award:

Dr. Li Pinglin appears to be an exceptional candidate for the Best Researcher Award based on his extensive academic background, significant research contributions, and impact on marine natural product chemistry.

🎓Education :

Dr. Li Pinglin completed his Ph.D. in Organic Chemistry from Lanzhou University, China, in 2008, where he focused on organic chemistry with an emphasis on bioactive natural products. Before this, he earned his B.S. in Chemistry from the same institution in 2003. Dr. Li’s educational journey laid a solid foundation for his career in marine natural product chemistry. His research expertise has been honed through advanced studies and a variety of collaborations, including his tenure as a visiting scholar at the Scripps Institution of Oceanography at UCSD, USA, from 2015-2016. Dr. Li’s academic achievements reflect his deep understanding of organic and marine chemistry, making him a leader in the study of marine bioactive compounds.

🏢Experience:

Dr. Li Pinglin has a robust academic and research background at the Ocean University of China. Since 2016, he has served as a professor at the School of Medicine and Pharmacy, where he teaches and conducts research on marine natural products and bioactive compounds. Before becoming a professor, Dr. Li held positions as an associate professor and lecturer at the same institution. He began his academic career at the College of Food Science and Engineering, Ocean University of China, where he taught from 2008. In addition to his academic roles, Dr. Li expanded his international exposure as a visiting scholar at the Scripps Institution of Oceanography, UCSD, USA, where he collaborated with experts in marine biology. His academic career is marked by significant contributions to the understanding of marine natural products, particularly focusing on the isolation and structural determination of bioactive metabolites.

🏅Awards and Honors :

Dr. Li Pinglin has received numerous accolades throughout his career, highlighting his outstanding contributions to the field of organic chemistry and marine natural products. In 2013, he was honored with the Sanofi Biopharmaceuticals Award for Youth by the Chinese Pharmaceutical Association for his exceptional work in the discovery and development of bioactive natural products from marine sources. His innovative research has attracted significant funding from the National Natural Science Foundation of China, where he has served as the chief investigator for multiple research projects. Dr. Li’s work is recognized not only in China but also internationally, further evidenced by his tenure as a visiting scholar at the prestigious Scripps Institution of Oceanography. These honors reflect his leadership in the marine natural product field, particularly in the exploration of marine organisms for new, bioactive compounds.

🔬Research Focus :

Dr. Li Pinglin’s research focuses on the isolation, structural determination, and bioassay of bioactive secondary metabolites derived from marine invertebrates, including sponges and corals, as well as their associated microorganisms. His primary research interests are in the chemical ecology of marine organisms, particularly in the South China Sea, where he investigates the potential of marine natural products for pharmaceutical applications. Dr. Li is also deeply involved in quantum calculation studies, focusing on electronic circular dichroism (ECD), nuclear magnetic resonance (NMR), and optical rotation values to determine the structures of these compounds. Additionally, his research includes the semi-synthesis of marine-derived bioactive natural products, which has led to the discovery of numerous compounds with promising biological activities. Dr. Li’s work contributes to the understanding of marine biodiversity and its potential in drug development, particularly in combating diseases through novel, bioactive compounds.

Publication Top Notes:

  • “Terpenoids from the Soft Coral Sinularia densa Collected in the South China Sea”
  • “Lemneolemnanes A–D, Four Uncommon Sesquiterpenoids from the Soft Coral Lemnalia sp.”